Related Experiment Video
Updated: Sep 17, 2025
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
2.5D deep learning radiomics and clinical data for predicting occult lymph node metastasis in lung adenocarcinoma
Xiaoxin Huang1,2, Xiaoxiao Huang3, Kui Wang1
1Medical Imaging Center, Guangxi Medical University Cancer Hospital, Liangyu Avenue, Wuxiang New District, Nanning City, Guangxi Zhuang Autonomous Region, 530021, China.
Background:
Occult lymph node metastasis (OLNM) refers to lymph node involvement that remains undetectable by conventional imaging techniques, posing a significant challenge in the accurate staging of lung adenocarcinoma. This study aims to investigate the potential of combining 2.5D deep learning radiomics with clinical data to predict OLNM in lung adenocarcinoma.
Methods:
Retrospective contrast-enhanced CT images were collected from 1,099 patients diagnosed with lung adenocarcinoma across two centers. Multivariable analysis was performed to identify independent clinical risk factors for constructing clinical signatures. Radiomics features were extracted from the enhanced CT images to develop radiomics signatures. A 2.5D deep learning approach was used to extract deep learning features from the images, which were then aggregated using multi-instance learning (MIL) to construct MIL signatures. Deep learning radiomics (DLRad) signatures were developed by integrating the deep learning features with radiomic features. These were subsequently combined with clinical features to form the combined signatures. The performance of the resulting signatures was evaluated using the area under the curve (AUC).
Results:
The clinical model achieved AUCs of 0.903, 0.866, and 0.785 in the training, validation, and external test cohorts The radiomics model yielded AUCs of 0.865, 0.892, and 0.796 in the training, validation, and external test cohorts. The MIL model demonstrated AUCs of 0.903, 0.900, and 0.852 in the training, validation, and external test cohorts, respectively. The DLRad model showed AUCs of 0.910, 0.908, and 0.875 in the training, validation, and external test cohorts. Notably, the combined model consistently outperformed all other models, achieving AUCs of 0.940, 0.923, and 0.898 in the training, validation, and external test cohorts.
Conclusion:
The integration of 2.5D deep learning radiomics with clinical data demonstrates strong capability for OLNM in lung adenocarcinoma, potentially aiding clinicians in developing more personalized treatment strategies.
